AWARD winning micro technology company Malvern Instruments Ltd has made two American acquisitions to extend its portfolio of analytical solutions for the rapidly advancing biopharmaceutical industry.

It has taken over MicroCal, which is based in Northampton, Massachusetts, from GE Healthcare Life Sciences and also purchased the Archimedes particle characterization system from Affinity Biosensors LLC of Santa Barbara, California.

“I am delighted to be announcing the completion of Malvern’s acquisition of MicroCal from GE Healthcare Life Sciences and our purchase of the Archimedes system from Affinity Biosensors,” said Malvern’s managing director Paul Walker. “MicroCal microcalorimeters are an exciting and important new addition to Malvern’s portfolio that will significantly extend our ability to serve customers working in pharmaceutical and biopharmaceutical discovery, development and formulation. I’d like to welcome all our new MicroCal colleagues around the world, and look forward to the rapid and productive integration of our businesses.

"Affinity Biosensors’ Archimedes system has brought the technique of resonant mass measurement into our range, and its close fit within our biopharmaceutical offering has encouraged us to secure its place and future development within Malvern."